Kyung Dong Pharmaceutical Co. Ltd (011040) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.025x

Based on the latest financial reports, Kyung Dong Pharmaceutical Co. Ltd (011040) has a cash flow conversion efficiency ratio of 0.025x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.70 Billion ≈ $3.86 Million USD) by net assets (₩229.60 Billion ≈ $155.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 011040 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Kyung Dong Pharmaceutical Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Kyung Dong Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Kyung Dong Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kyung Dong Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
J W Mays Inc NASDAQ:MAYS	0.028x
Autocount Dotcom Berhad KLSE:0276	0.035x
Webus International Limited Ordinary Shares NASDAQ:WETO	0.006x
Compass Digital Acquisition Corp NASDAQ:CDAQ	0.037x
BaoMinh Insurance Corp VN:BMI	0.005x
Neuronetics Inc NASDAQ:STIM	-0.552x
Nexstim Oyj HE:NXTMH	0.099x
Heng Sheng Holding Group Limited KQ:900270	0.011x

Annual Cash Flow Conversion Efficiency for Kyung Dong Pharmaceutical Co. Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Kyung Dong Pharmaceutical Co. Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Kyung Dong Pharmaceutical Co. Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩228.87 Billion ≈ $155.10 Million	₩16.93 Billion ≈ $11.48 Million	0.074x	+301.66%
2024-12-31	₩220.06 Billion ≈ $149.13 Million	₩-8.07 Billion ≈ $-5.47 Million	-0.037x	-26148.62%
2023-12-31	₩228.48 Billion ≈ $154.84 Million	₩-31.94 Million ≈ $-21.64K	0.000x	+96.66%
2022-12-31	₩257.20 Billion ≈ $174.30 Million	₩-1.07 Billion ≈ $-728.49K	-0.004x	-108.74%
2021-12-31	₩259.82 Billion ≈ $176.08 Million	₩12.42 Billion ≈ $8.42 Million	0.048x	-26.76%
2020-12-31	₩262.19 Billion ≈ $177.68 Million	₩17.12 Billion ≈ $11.60 Million	0.065x	+632.25%
2019-12-31	₩226.71 Billion ≈ $153.64 Million	₩-2.78 Billion ≈ $-1.88 Million	-0.012x	-107.81%
2018-12-31	₩211.72 Billion ≈ $143.48 Million	₩33.27 Billion ≈ $22.55 Million	0.157x	+134.79%
2017-12-31	₩220.95 Billion ≈ $149.74 Million	₩14.79 Billion ≈ $10.02 Million	0.067x	-45.18%
2016-12-31	₩209.93 Billion ≈ $142.26 Million	₩25.63 Billion ≈ $17.37 Million	0.122x	+37.17%
2015-12-31	₩205.14 Billion ≈ $139.02 Million	₩18.26 Billion ≈ $12.37 Million	0.089x	-25.43%
2014-12-31	₩190.43 Billion ≈ $129.05 Million	₩22.73 Billion ≈ $15.40 Million	0.119x	+22.85%
2013-12-31	₩169.03 Billion ≈ $114.55 Million	₩16.42 Billion ≈ $11.13 Million	0.097x	-25.16%
2012-12-31	₩153.76 Billion ≈ $104.20 Million	₩19.96 Billion ≈ $13.53 Million	0.130x	-25.02%
2011-12-31	₩150.62 Billion ≈ $102.07 Million	₩26.08 Billion ≈ $17.67 Million	0.173x	--

About Kyung Dong Pharmaceutical Co. Ltd

KQ:011040 Korea Pharmaceuticals

Market Cap

$83.52 Million

₩123.24 Billion KRW

Market Cap Rank

#19964 Global

#1055 in Korea

Share Price

₩5240.00

Change (1 day)

+1.35%

52-Week Range

₩4855.00 - ₩6200.00

All Time High

₩14206.86